Trade

with

AngioDynamics Inc
(NASDAQ: ANGO)
AdChoices
16.29
-0.16
-0.97%
After Hours :
16.29
0.00
0.00%

Open

16.26

Previous Close

16.45

Volume (Avg)

294.17k (212.47k)

Day's Range

16.20-16.45

52Wk Range

13.06-19.00

Market Cap.

586.48M

Dividend Rate ( Yield )

-

Beta

0.81

Shares Outstanding

35.65M

P/E Ratio (EPS)

149.25 (0.11)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Medical Instruments & Supplies
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 354.46M

    • Net Income

    • 3.09M

    • Market Cap.

    • 586.48M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 1.10

    • PEG (Price/Earnings Growth) Ratio

    • 1.88

    • Beta

    • 0.81

    • Forward P/E

    • 28.82

    • Price/Sales

    • 1.64

    • Price/Book Value

    • 1.09

    • Price/Cash flow

    • 24.63

      • EBITDA

      • 34.94M

      • Return on Capital %

      • 0.49

      • Return on Equity %

      • 0.74

      • Return on Assets %

      • 0.49

      • Book Value/Share

      • 15.14

      • Shares Outstanding

      • 35.65M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Buy
        • 1 Year Price Target

        • 21.00

        • Credit Rating

        • -

        • Analysts

        • 2

        • EPS Estimate

        • 0.24

        • Cashflow Estimate

        • 0.93

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 4.40

          • 10.42

          • Net Income

            YTD/YTD (last year)

          • -

          • -15.59

          • Net Income

            Q/Q (last year)

          • -

          • -8.93

          • Sales (Revenue)

            5-Year Annual Average

          • 12.69

          • 12.51

          • Net Income

            5-Year Annual Average

          • -20.80

          • 4.16

          • Dividends

            5-Year Annual Average

          • -

          • 0.97

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 51.13

            • 52.83

            • Pre-Tax Margin

            • 2.33

            • 15.96

            • Net Profit Margin

            • 1.10

            • 12.40

            • Average Gross Margin

              5-Year Annual Average

            • 54.80

            • 52.66

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 2.70

            • 18.40

            • Average Net Profit Margin

              5-Year Annual Average

            • 1.60

            • 93.46B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.25

              • 0.62

              • Current Ratio

              • 2.42

              • 1.97

              • Quick Ratio

              • 1.12

              • 1.16

              • Interest Coverage

              • 3.61

              • 10.47

              • Leverage Ratio

              • 1.48

              • 2.38

              • Book Value/Share

              • 15.14

              • 12.11

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 147.06

                • 35.97

                • P/E Ratio 5-Year High

                • 172.42

                • 279.76

                • P/E Ratio 5-Year Low

                • 86.35

                • 148.87

                • Price/Sales Ratio

                • 1.60

                • 3.33

                • Price/Book Value

                • 1.06

                • 4.16

                • Price/Cash Flow Ratio

                • 24.63

                • 17.27

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • 0.74

                    (0.90)

                  • 17.93

                    (21.42)

                  • Return on Assets %

                    (5-Year Average)

                  • 0.49

                    (0.90)

                  • 7.35

                    (9.50)

                  • Return on Capital %

                    (5-Year Average)

                  • 0.89

                    (1.20)

                  • 10.24

                    (13.59)

                  • Income/Employee

                  • 3.02k

                  • 25.65k

                  • Inventory Turnover

                  • 2.70

                  • 2.66

                  • Asset Turnover

                  • 0.45

                  • 0.59

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  13.45M
                  Operating Margin
                  3.79
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  24.63
                  Ownership

                  Institutional Ownership

                  64.75%

                  Top 10 Institutions

                  42.22%

                  Mutual Fund Ownership

                  23.07%

                  Float

                  70.22%

                  5% / Insider Ownership

                  9.04%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • DFA US Small Cap Value II Portfolio

                  •  

                    810,217

                  • 0.16

                  • 2.28

                  • Royce Opportunity Fund

                  •  

                    601,840

                  • 3.94

                  • 1.69

                  • iShares Core S&P Small-Cap (AU)

                  •  

                    513,030

                  • 0.57

                  • 1.70

                  • Vanguard Total Stock Mkt Idx

                  •  

                    407,128

                  • 0.00

                  • 1.14

                  • iShares Russell 2000 (AU)

                  •  

                    372,142

                  • -1.82

                  • 1.23

                  • Vanguard Extended Market Index Fund

                  •  

                    333,215

                  • 0.46

                  • 0.93

                  • Transamerica Small/Mid Cap Value

                  •  

                    299,500

                  • 8.91

                  • 0.85

                  • Transamerica Systematic S/M Cap Val VP

                  •  

                    247,550

                  • 18.73

                  • 0.70

                  • iShares S&P Small-Cap 600 Value

                  •  

                    215,938

                  • -0.37

                  • 0.71

                  • DFA U.S. Micro Cap Portfolio

                  •  

                    211,859

                  • 0.35

                  • 0.60

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • RGM Capital LLC

                  •  

                    3,467,199

                  • +1.87%

                  • 9.78

                  • Broadfin Capital, LLC

                  •  

                    2,970,510

                  • +14.57%

                  • 8.38

                  • Dimensional Fund Advisors, Inc.

                  •  

                    2,401,248

                  • +3.29%

                  • 6.78

                  • Systematic Financial Management L.P.

                  •  

                    1,120,719

                  • +10.22%

                  • 3.16

                  • Vanguard Group, Inc.

                  •  

                    922,080

                  • +2.38%

                  • 2.60

                  • BlackRock Fund Advisors

                  •  

                    895,638

                  • -1.23%

                  • 2.53

                  • Royce & Associates, LLC

                  •  

                    839,013

                  • +8.60%

                  • 2.37

                  • LAPIDES ASSET MANAGEMENT, LLC

                  •  

                    824,800

                  • +1.79%

                  • 2.33

                  • Thomson Horstmann & Bryant, Inc.

                  •  

                    822,736

                  • +7.00%

                  • 2.31

                  • Northern Trust Investments, N.A.

                  •  

                    702,189

                  • -1.08%

                  • 1.98

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Medical Instruments & Supplies

                  Type

                  Speculative Growth

                  Style

                  Small Core

                  AngioDynamics Inc was incorporated in 1988 in Delaware. The Company designs, manufactures and sells medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripher...moreal vascular disease and for use in oncology and surgical settings. The Company is organized in two segments: Vascular and Oncology/Surgery. The Oncology/Surgery Division includes Radiofrequency Ablation (RFA) and NanoKnife product lines. This division also includes the microwave ablation technology products obtained through the acquisition of Microsulis Medical Ltd. The Vascular division manages Fluid Management, Venous, AngioVac, Angiographic, PTA, Drainage, Thrombolytic, Micro Access Kits, Dialysis, PICC and Port product lines. The Company’s product include the NAMIC F...moreluid Management portfolio. The NAMIC product line includes an extensive offering of manifolds, contrast management systems, closed fluid systems, guidewires, disposable transducers and interventional accessories. The devices are utilized together and allow clinicians to aspirate or inject contrast, saline, remove waste and monitor invasive blood pressures throughout the procedure. The venous products consist of our VenaCure EVLT laser system and Sotradecol. The AngioVac devices are for use with other manufacturer’s off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of a extracorporeal bypass procedure for up to six hours. Thrombolytic catheters are used to deliver thrombolytic agents, which are drugs that dissolve blood clots in hemodialysis access grafts, arteries, veins and surgical bypass grafts. The micro access sets provide interventional physicians a smaller introducer system for minimally-invasive procedures. Image-guided vascular access, or IGVA, involves the use of advanced imaging equipment to guide the placement of catheters that deliver primarily short-term drug therapies, such as chemotherapeutic agents and antibiotics, into the central venous system. Radiofrequency Ablation (RFA) products use radiofrequency energy to provide a minimally invasive approach to ablating solid cancerous or benign tumors. The NanoKnife Ablation System is for the surgical ablation of soft tissue. The NanoKnife Ablation System utilizes low energy direct current electrical pulses to permanently open pores in target cell membranes. The treated tissue is then removed by the body’s natural processes in a matter of weeks, mimicking natural cell death. The Acculis Microwave Tissue Ablation (MTA) System complements the full range of ablative technologies. The Company competes with Boston Scientific Corporation; Cook Medical; Cordis Corporation, a subsidiary of Johnson & Johnson, Inc.; C.R. Bard; Medical Components, Inc., or Medcomp; Arrow International, a subsidiary of TeleFlex Medical; Smiths Medical, a subsidiary of Smiths Group PLC; Vascular Solutions; Covidien subsidiaries (Kendall, VNUS, EV3) and Merit Medical. The Company’s sales and marketing efforts are engaged in interventional radiologists, interventional cardiologists, vascular surgeons, urologists and interventional and surgical oncologists. It has 5,000 interventional radiologists, 5,000 interventional cardiologists, 2,000 vascular surgeons, 9,000 urologists and 2,000 interventional and surgical oncologists in the United States. The Company has 450 patents and have approximately 285 patent applications pending in the United States and in certain other countries that relate to aspects of the technology used in many of our products. The products manufactured and marketed are subject to regulation by the FDA under the Federal Food, Drug, and Cosmetic Act, or FDCA, and, in some instances, state authorities and foreign governments.lessless

                  Key People

                  Mr. Joseph M. Devivo

                  CEO/President/Director

                  Mr. Howard W. Donnelly

                  Director/Chairman of the Board

                  Mark T. Frost

                  CFO/Chief Accounting Officer/Executive VP/Treasurer

                  John Soto

                  Executive VP/Other Executive Officer

                  Mr. Dennis S. Meteny

                  Director

                  • AngioDynamics Inc

                  • 14 Plaza Drive

                  • Latham, NY 12110

                  • USA.Map

                  • Phone: +1 518 795-1400

                  • Fax: +1 518 795-1401

                  • angiodynamics.com

                  Incorporated

                  1988

                  Employees

                  1,300

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: